Long-term independent predictors of positive response to cardiac resynchronization therapy

Aims Cardiac resynchronization therapy (CRT) is currently considered an important breakthrough in the treatment of selected patients with refractory heart failure. However, long-term predictors of mortality, morbidity and time to recovery of ventricular function for those patients who respond positively to CRT remain poorly investigated. Methods This is a retrospective follow-up study involving one hospital. Between August 2004 and October 2008, 211 consecutive patients with refractory heart failure received a CRT device in the Cardiology Division of Ospedale Civile Maggiore in Verona. The clinical characteristics studied were age, sex, heart rhythm, left ventricular end-systolic volume/body surface area (LVESV/BSA), left ventricular ejection fraction, QRS duration, type of bundle-branch block, cause, New York Heart Association functional class, pharmacological therapy and lead position. The objective of this study was to evaluate the effect of several baseline characteristics on long-term prognosis in heart failure patients treated with CRT. Results Non ischemic cause, left bundle-branch block and a basal LVESV/BSA ⩽106 ml/m2 or less were the only independent predictors of a positive response to CRT (P < 0.005). Additionally, a reduction in LVESV/BSA after CRT was associated both with increased survival and reduced rehospitalization for heart failure (P < 0.005). Conclusion A better selection of patients on the basis of cause, type of bundle-branch block and basal LVESV/BSA can increase the number of patients that would benefit from CRT.

[1]  R. Cappato,et al.  Predictors for restoration of normal left ventricular function in response to cardiac resynchronization therapy measured at time of implantation. , 2011, The American journal of cardiology.

[2]  Jeroen J. Bax,et al.  Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome. , 2010, European heart journal.

[3]  P. Marzullo,et al.  CRT in Patients with Heart Failure: Time Course of Perfusion and Wall Motion Changes , 2010, Cardiology research and practice.

[4]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[5]  I. V. Van Gelder,et al.  Impact of interventricular lead distance and the decrease in septal-to-lateral delay on response to cardiac resynchronization therapy. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  J. Ornato,et al.  ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2008, Heart rhythm.

[7]  M. Haghjoo,et al.  Significance of QRS morphology in determining the prevalence of mechanical dyssynchrony in heart failure patients eligible for cardiac resynchronization: particular focus on patients with right bundle branch block with and without coexistent left-sided conduction defects. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  C. Vahlhaus,et al.  Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy , 2007, Heart.

[9]  Carolyn Apperson-Hansen,et al.  Usefulness of atrioventricular delay optimization using Doppler assessment of mitral inflow in patients undergoing cardiac resynchronization therapy. , 2006, The American journal of cardiology.

[10]  N. Freemantle,et al.  Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction — a systematic review and meta‐analysis , 2006, European journal of heart failure.

[11]  Jeroen J. Bax,et al.  Effect of Posterolateral Scar Tissue on Clinical and Echocardiographic Improvement After Cardiac Resynchronization Therapy , 2006, Circulation.

[12]  David L Hayes,et al.  Sustained Reverse Left Ventricular Structural Remodeling With Cardiac Resynchronization at One Year Is a Function of Etiology: Quantitative Doppler Echocardiographic Evidence From the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) , 2006, Circulation.

[13]  Jeroen J. Bax,et al.  Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. , 2006, The American journal of cardiology.

[14]  J. Le Heuzey,et al.  Determinants of Mortality in Patients Undergoing Cardiac Resynchronization Therapy: Baseline Clinical, Echocardiographic, and Angioscintigraphic Evaluation Prior to Resynchronization , 2005, Pacing and clinical electrophysiology : PACE.

[15]  Lluís Mont,et al.  Predictors of lack of response to resynchronization therapy. , 2005, The American journal of cardiology.

[16]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[17]  J. Jarcho.  Resynchronizing ventricular contraction in heart failure. , 2005, The New England journal of medicine.

[18]  M. Gold,et al.  Comparison of stimulation sites within left ventricular veins on the acute hemodynamic effects of cardiac resynchronization therapy. , 2005, Heart rhythm.

[19]  Jeroen J. Bax,et al.  Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. , 2004, The American journal of cardiology.

[20]  E. Foster,et al.  Effects of Resynchronization Therapy on Cardiac Function in Pacemaker Patients “Upgraded” to Biventricular Devices , 2004, Journal of cardiovascular electrophysiology.

[21]  Andrea Corrado,et al.  Impact of Coronary Sinus Lead Position on Biventricular Pacing: , 2004, Journal of cardiovascular electrophysiology.

[22]  V. Thohan.  Prognostic implications of echocardiography in advanced heart failure , 2004, Current opinion in cardiology.

[23]  M. Haïssaguerre,et al.  Interventricular and intra-left ventricular electromechanical delays in right ventricular paced patients with heart failure: implications for upgrading to biventricular stimulation , 2003, Heart.

[24]  R. Canby,et al.  Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.

[25]  F. Follath,et al.  One-year mortality among unselected outpatients with heart failure. , 2002, European heart journal.

[26]  H. Halperin,et al.  Systolic Improvement and Mechanical Resynchronization Does Not Require Electrical Synchrony in the Dilated Failing Heart With Left Bundle-Branch Block , 2002, Circulation.

[27]  S. Fisher,et al.  QRS duration and mortality in patients with congestive heart failure. , 2002, American heart journal.

[28]  N. Kanuru,et al.  Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. , 2002, Journal of the American College of Cardiology.

[29]  Luigi Tavazzi,et al.  Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. , 2002, American heart journal.

[30]  E Fleck,et al.  Effect of Resynchronization Therapy Stimulation Site on the Systolic Function of Heart Failure Patients , 2001, Circulation.

[31]  J. Daubert,et al.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. , 2001, The New England journal of medicine.

[32]  J. Daubert,et al.  A pilot experience with permanent biventricular pacing to treat advanced heart failure. , 2000, American heart journal.

[33]  M. Block,et al.  Pacing Therapies in Congestive Heart Failure II study. , 2000, The American journal of cardiology.

[34]  Andrew P. Kramer,et al.  Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay. , 2000, Circulation.

[35]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[36]  C. Leclercq,et al.  Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation. , 2000, The American journal of cardiology.

[37]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[38]  S. Anker,et al.  Intraventricular conduction delay: a prognostic marker in chronic heart failure. , 1999, International journal of cardiology.

[39]  Andrew P. Kramer,et al.  Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. , 1999, Circulation.

[40]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[41]  M. Hetzel,et al.  Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). , 1997, Circulation.

[42]  Hugh Tunstall-Pedoe,et al.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population , 1997, The Lancet.

[43]  R. Doughty,et al.  Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease , 1997 .

[44]  Australia..  Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease , 1997, The Lancet.

[45]  D. Levy,et al.  Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects , 1993, Circulation.

[46]  J. Cohn,et al.  Prognostic Significance of Serial Changes in Left Ventricular Ejection Fraction in Patients With Congestive Heart Failure , 1993, Circulation.

[47]  F. Tristani,et al.  Ejection Fraction, Peak Exercise Oxygen Consumption, Cardiothoracic Ratio, Ventricular Arrhythmias, and Plasma Norepinephrine as Determinants of Prognosis in Heart Failure , 1993, Circulation.

[48]  D G Gibson,et al.  Effects of abnormal activation on the time course of the left ventricular pressure pulse in dilated cardiomyopathy , 1992, British heart journal.

[49]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[50]  B. Pitt,et al.  Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. , 1989, Journal of the American College of Cardiology.

[51]  C. Grines,et al.  Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. , 1989, Circulation.

[52]  C. Gauntt,et al.  Interferon and natural killer cell activity in coxsackie virus B3-induced murine myocarditis , 1987 .

[53]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[54]  Finn Gustafsson,et al.  2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .

[55]  Arma,et al.  EFFECTS OF MULTISITE BIVENTRICULAR PACING IN PATIENTS WITH HEART FAILURE AND INTRAVENTRICULAR CONDUCTION DELAY , 2001 .

[56]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.